Evidence map›Paper›PMID 33375300›Full record

ArticleInternational journal of environmental research and public health2020

Thought Suppression in Primary Psychotic Disorders and Substance/Medication Induced Psychotic Disorder.

Cosmin O Popa, Razvan Predatu, Wesley C Lee, Petronela Blaga, Eliza Sirbu, Adrian V Rus, Alexander Clark, Cristiana Cojocaru, Alina Schenk, Vitalie Vacaras and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Cosmin O PopaDepartment of Ethics and Social Sciences, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Tirgu-Mures, Romania.ORCID 0000-0002-3155-9291
Razvan PredatuInternational Institute for the Advanced Studies of Psychotherapy and Applied Mental Health, Babeș-Bolyai University, 400015 Cluj-Napoca, Romania.ORCID 0000-0003-4211-3540
Wesley C LeeDepartment of Social and Behavioral Sciences, Southwestern Christian University, Bethany, OK 73008, USA.
Petronela BlagaInternational Institute for the Advanced Studies of Psychotherapy and Applied Mental Health, Babeș-Bolyai University, 400015 Cluj-Napoca, Romania.
Eliza SirbuDoctoral School of George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Tirgu-Mures, Romania.
Adrian V RusDepartment of Social and Behavioral Sciences, Southwestern Christian University, Bethany, OK 73008, USA.ORCID 0000-0002-1603-4091
Alexander ClarkCollege of Education and Professional Studies, University of Central Oklahoma, Edmond, OK 73034, USA.
Cristiana CojocaruDoctoral School of George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Tirgu-Mures, Romania.ORCID 0000-0002-7344-5882
Alina SchenkDoctoral School of George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Tirgu-Mures, Romania.
Vitalie VacarasNeurology Department, Cluj Emergency County Hospital, 400006 Cluj-Napoca, Romania.
Simona SzaszDepartment of Rheumatology, Physical and Rehabilitation Medicine, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Tirgu-Mures, Romania.
Simona MuresanDepartment of Internal Medicine, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Tirgu-Mures, Romania.
Cristina BrediceanDepartment of Neuroscience, Victor Babeș University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · ROBabeș-Bolyai University · ROSouthwestern Christian University · USSpitalul Clinic Județean de Urgență Cluj-Napoca · ROUniversity of Central Oklahoma · USVictor Babeș University of Medicine and Pharmacy Timișoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFirst episode-psychosis (FEP) represents a stressful/traumatic event for patients. To our knowledge, no study to date has investigated thought suppression involved in FEP in a Romanian population. Our objective was to investigate thought suppression occurring during FEP within primary psychotic disorders (PPD) and substance/medication induced psychotic disorders (SMIPD). Further, we examined the relationship between thought suppression and negative automatic thoughts within PPD and SMIPD.

methodsThe study included 30 participants (17 females) with PPD and 25 participants (10 females) with SMIPD. Psychological scales were administered to assess psychotic symptoms and negative automatic thoughts, along a psychiatric clinical interview and a biochemical drug test.

resultsParticipants in the PPD group reported higher thought suppression compared to SMIPD group. For the PPD group, results showed a positive correlation between thought suppression and automatic thoughts. For the SMIPD group, results also showed a positive correlation between thought suppression and automatic thoughts.

conclusionsPatients with PPD rely more on thought suppression, as opposed to SMIPD patients. Thought suppression may be viewed as an unhealthy reaction to FEP, which is associated with the experience of negative automatic thoughts and might be especially problematic in patients with PPD. Cognitive behavioral therapy is recommended to decrease thought suppression and improve patients' functioning.

Indexed as

Inhibition, PsychologicalThinkingFemaleHumansNegativismPsychoses, Substance-InducedPsychotic DisordersSubstance-Related Disordersautomatic thoughtscognitive behavioral therapyfirst-episode psychosisprimary psychotic disordersstress-related growthsubstance/medication induced psychotic disorderthought suppression

Identifiers

PMID33375300
PMCPMC7795668
OpenAlexW3117549881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.